iCell DopaNeurons PD GBA N370S, 11344 and Isogenic Control

Disease Model

Kit Size

Catalog #: R1229
Catalog #: R1231
Catalog #: R1230

Cells Only

Catalog #: C1147
Catalog #: C1148
Catalog #: C1148

DopaNeurons Parkinson's Disease differentiated from human iPS cells, frozen

From
$1,195.00

Isogenic Control

Kit Size

Catalog #: R1255

Cells Only

Catalog #: C1258
Catalog #:

DopaNeurons Parkinson's Disease differentiated from human iPS cells, frozen

From
$1,595.00
Catalog # AN370S

Product Overview

Mutations in GBA gene are a common genetic risk factor for Parkinson’s disease (PD), occurring in > 5% of all cases. The GBA gene encodes glucocerebrosidase (GCase), a lysosomal enzyme that metabolizes glucocerebroside into ceramide and glucose. The GBA N370S mutation is associated aberrant α-synuclein aggregation, reduced GCase activity, malfunction of the autophagy-lysosomal pathway, and endosomal stress.

iCell® DopaNeurons PD GBA N370S were derived from induced pluripotent stem (iPS) cells from the Parkinson's Progression Markers Initiative (PPMI). Sponsored by The Michael J. Fox Foundation, PPMI partnered with FUJIFILM Cellular Dynamics (FCDI) to produce a large bank of Parkinson’s donor-derived iPS cells, including lines harboring Parkinson’s-associated genetic mutations, such as GBA N370S. Each cell line is supported by PPMI donor clinical, imaging, genomics, and biological data. (www.ppmi-info.org)

To enable investigation of the functional consequences of the mutation within this patient-derived line, we used genetic engineering to generate a N370S/N mutation-corrected isogenic cell line from the same donor.

iCell DopaNeurons lines are differentiated into human midbrain floorplate dopaminergic (DA) neurons according to protocols licensed and adapted from the Lorenz Studer lab (Memorial Sloan Kettering) and industrialized at FCDI.

Benefits of iCell DopaNeurons PD GBA N370S and isogenic GBA N370S/N cell lines:

  • Fully differentiated, >80% pure midbrain DA neurons derived from GBA N370S donor iPS cells
  • Express midbrain dopaminergic neuron markers (e.g., Lmx1, FoxA2, and TH)
  • Isogenic control GBA N370S/N mutation-corrected cell line is available.
  • iCell DopaNeurons PD GBA N370S exhibit:
    • Reduced GCase activity
    • Altered dopamine metabolism
    • Elevated alpha-synuclein protein accumulation
    • Increased neuronal degeneration compared to the apparently healthy normal control iCell DopaNeurons
  • Accessible and consistent model for discovery and toxicology research of Parkinson’s disease.
  • View all Parkinson’s Disease iCell DopaNeurons cell lines

Components:

Need Help With This Product?

Our specialists are here to help you find the best product for your application.

Our regular business hours are 9:00am to 5:00pm Central Time (USA)

Need Help With This Product?

Our specialists are here to help you find the best product for your application.

Our regular business hours are 9:00am to 5:00pm Central Time (USA)

Performance Data

Applications

  • Drug targeted screening
  • Neurotoxicology
  • Parkinson’s disease modeling
  • Gaucher’s disease modeling

Product Highlights

Easy to implement

Shipped cryopreserved with optimized media. Simply thaw and use.

High throughput

Available in multiple unit sizes to support both scalable research and drug screening programs.

Consistent culture

80% tyrosine hydroxylase (TH)-positive dopaminergic neurons provides a robust and reproducible cell culture system.

Backed by clinical data

Generated in partnership with the PPMI and supported by patient clinical information. Visit PPMI for more information.

Biologically relevant

Derived from Parkinson’s Disease donor material and selected for common disease-associated gene mutations.

Publications